100 related articles for article (PubMed ID: 27109271)
1. The impact of antiretroviral therapy in resource-limited settings and current HIV therapeutics.
Kumarasamy N
Oral Dis; 2016 Apr; 22 Suppl 1():42-5. PubMed ID: 27109271
[TBL] [Abstract][Full Text] [Related]
2. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
3. How many people living with HIV will be additionally eligible for antiretroviral treatment in Karnataka State, India as per the World Health Organization 2013 guidelines?
Dodderi SK; Kumar AM; Naik BR; Kanchar A; B B R; Harries AD
PLoS One; 2014; 9(9):e107136. PubMed ID: 25192338
[TBL] [Abstract][Full Text] [Related]
4. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
Bigna JJ; Plottel CS; Koulla-Shiro S
Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
[TBL] [Abstract][Full Text] [Related]
5. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
6. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
Kumarasamy N; Krishnan S
Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral use during pregnancy for treatment or prophylaxis.
Sturt AS; Read JS
Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
[TBL] [Abstract][Full Text] [Related]
8. Integrating HIV management for children into the Integrated Management of Childhood Illness guidelines.
Qazi SA; Muhe LM
Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):10-3. PubMed ID: 16257023
[TBL] [Abstract][Full Text] [Related]
9. Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India.
Solomon SS; Lucas GM; Kumarasamy N; Yepthomi T; Balakrishnan P; Ganesh AK; Anand S; Moore RD; Solomon S; Mehta SH
AIDS Care; 2013 Aug; 25(8):931-6. PubMed ID: 23216257
[TBL] [Abstract][Full Text] [Related]
10. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
11. Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings?
Gallant JE; Mehta SH; Sugarman J
Clin Infect Dis; 2013 Sep; 57(6):884-7. PubMed ID: 23759345
[TBL] [Abstract][Full Text] [Related]
12. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.
Gilks CF; Crowley S; Ekpini R; Gove S; Perriens J; Souteyrand Y; Sutherland D; Vitoria M; Guerma T; De Cock K
Lancet; 2006 Aug; 368(9534):505-10. PubMed ID: 16890837
[TBL] [Abstract][Full Text] [Related]
13. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
Bryant L; Smith N; Keiser P
J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
De Luca A; Hamers RL; Schapiro JM
J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
[TBL] [Abstract][Full Text] [Related]
15. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples.
Gupta S; Granich R; Suthar AB; Smyth C; Baggaley R; Sculier D; Date A; Desai MA; Lule F; Raizes E; Blanc L; Hirnschall G
J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e87-97. PubMed ID: 23187942
[TBL] [Abstract][Full Text] [Related]
16. HIV in the tropics: staging in the resource-limited setting.
Varughese JK; Rosenberg MG; Kim K
Curr Opin Infect Dis; 2012 Oct; 25(5):477-83. PubMed ID: 22744319
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
[TBL] [Abstract][Full Text] [Related]
18. Adoption of the 2015 World Health Organization guidelines on antiretroviral therapy: Programmatic implications for India.
Rewari BB; Agarwal R; Shastri S; Nagaraja SB; Rathore AS
WHO South East Asia J Public Health; 2017 Apr; 6(1):90-93. PubMed ID: 28597865
[TBL] [Abstract][Full Text] [Related]
19. Management of HIV in resource limited settings.
McCutchan JA
Curr Opin Infect Dis; 2009 Oct; 22(5):464-70. PubMed ID: 19730283
[TBL] [Abstract][Full Text] [Related]
20. 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2.
Gottlieb GS; Raugi DN; Smith RA
Lancet HIV; 2018 Jul; 5(7):e390-e399. PubMed ID: 30052509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
